STANDARD BIOTOOLS INC - NOTE 2.750% 2/0

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Debt / NOTE 2.750% 2/0
Market price (% of par)
83.06%
Total 13F principal
$195,639,000
Principal change
+$7,519,000
Total reported market value
$162,372,000
Number of holders
22
Value change
+$9,014,579
Number of buys
5
Number of sells
10

Institutional Holders of STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 as of Q4 2017

As of 31 Dec 2017, STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 was held by 22 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $195,639,000 in principal (par value) of the bond. The largest 10 bondholders included Indaba Capital Management, L.P., Partner Fund Management, L.P., CITADEL ADVISORS LLC, FRANKLIN RESOURCES INC, AMERIPRISE FINANCIAL INC, SMH CAPITAL ADVISORS INC, ORBIMED ADVISORS LLC, SYMPHONY ASSET MANAGEMENT LLC, Invesco Ltd., and SILVERBACK ASSET MANAGEMENT LLC. This page lists 22 institutional bondholders reporting positions for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.